158th MSMS Foundation Annual Scientific Meeting (ASM) Virtual Monthly Series

Approved for 18 AMA PRA Category Credit(s)™

The MSMS ASM Planning Committee and our collaborating partners from around the state redesigned the delivery mechanism to allow physicians from the entire state to participate in virtual courses.  The ASM courses are also being recorded for on-demand viewing after each monthly meeting to allow a flexible education experience that works best with physician’s schedules.  

Remaining 2023 courses and dates include:

  • September 18 – Approach to Peripheral Neuropathy
  • October 23 – Dermatology Update
  • November 27 – Colon and Rectal Surgery
  • December 18 – Allergy and Asthma Update

Highlighted Upcoming ASM Series Sessions for September and October include:

Approach to Peripheral Neuropathy
Monday, September 18, 2023
6:00 – 8:00 pm

Approved for 2 AMA PRA Category 1 Credits™

Peripheral neuropathy is a general term that indicates any disorder of the peripheral nervous system.  Its numerous causes and diverse presentations make diagnosis and management difficult.  This course will highlight best practices to approach different types of neuropathies.


Iram Zaman, DO

How to Approach Patient with Peripheral Neuropathy

Kavita Grover, MD

Diabetic Neuropathies – Various Presentations: Diagnostic Work Up and Management

Anza Memon, MD

Paraproteinemia and Neuropathy

To Register, please click here:  Meeting Home Page (msms.org)

Dermatology Update

Monday, October 23, 2023

6:00 – 8:00 PM EST  

Approved for 2 AMA PRA Category Credit(s)™

This course will discuss IL-17A and IL-17F inhibitors across multiple disease pathways and implicit bias with a dermatology focus.  


  1. Define the role of IL-17A and IL-17F inhibitors across multiple disease pathways and how therapies target this pathway.
  2. Discuss the benefit-risk profiles of IL-17 inhibitors across multiple inflammatory diseases. 
  3. Discuss the differences between IL-17 inhibitors for the management of multiple inflammatory disease states. 
  4. Describe strategies on how to individualize care for their patients with IL-17 inhibitors.
  5. Discuss strategies to reduce disparities in access to and delivery of health care services.

Omar Qutub, MD, Defining Dermatology, Portland, OR
Combating Institutional Bias

Speaker TBD
IL-17 Inhibitors for the Management of Inflammatory Conditions: What do we Know Today?

To Register, please click here: 
Meeting Home Page (msms.org)

Registration Fees Per Course: 
Members – $50
Non-members – $75
Retired Members – $50
Member Students and Residents – FREE

For more information, contact Brenda Marenich at bmarenich@msms.org or 517-336-7580.

Statement of Accreditation
The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The MSMS designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.